Evidence map›Paper›PMID 38858329›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2024

Differential Effects of LOX-1 Inhibition on Aortic Structure and Posterior Cerebral Artery Structure and Function in an Experimental Model of Preeclampsia.

Jennifer L Anderson, Jayden A McGreer, Sarah M Tremble, Abigayle V Tainter-Gilbert, Marilyn J Cipolla

Abstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer L AndersonDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, 149 Beaumont Ave, Burlington, VT, 05405, USA. Jennifer.Anderson@uvm.edu.ORCID 0000-0003-1975-4032
Jayden A McGreerDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, 149 Beaumont Ave, Burlington, VT, 05405, USA.
Sarah M TrembleDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, 149 Beaumont Ave, Burlington, VT, 05405, USA.ORCID 0000-0002-2153-2714
Abigayle V Tainter-GilbertDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, 149 Beaumont Ave, Burlington, VT, 05405, USA.
Marilyn J CipollaDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, 149 Beaumont Ave, Burlington, VT, 05405, USA.ORCID 0000-0002-9172-5941

Funding

Hippocampal arteriole remodeling and brain injury in preeclampsia and eclampsiaR01NS108455 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CIPOLLA, MARILYN J · 2018 to 2022
$1.9M
Nikon A1R-ER Confocal Microscope for the Microscopy Imaging CenterS10OD025030 · OD · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TAATJES, DOUGLAS J. · 2018 to 2018
$557k
NCRR NIH HHS 1S10OD025030-01NIDA NIH HHS 1R01 NS108455NIEHS NIH HHS 1R01 NS108455NIH HHS S10 OD025030NIMH NIH HHS 1R01 NS108455NINDS NIH HHS 1R01 NS108455NINDS NIH HHS R01 NS108455
6 · The paper itself

Abstract

Preeclampsia is a hypertensive disorder of pregnancy marked by vascular dysfunction, large artery stiffness, and excess oxidized low-density lipoprotein (oxLDL). oxLDL activates oxidative stress pathways which contribute to arterial stiffness through interaction with the lectin-like oxLDL receptor 1 (LOX-1). Increased vascular stiffness is associated with higher pulse wave velocity and downstream microvasculature damage. Here we evaluated the ability of LOX-1 inhibition (LOX-1i) to prevent large artery structural and microvascular structural and functional changes via assessment of the descending thoracic aorta (DTAo) and posterior cerebral arteries (PCA) in a high cholesterol model of preeclampsia. Adult female Sprague Dawley normal late-pregnant (LP) and experimentally preeclamptic (ePE, high cholesterol diet d7-19) animals underwent intraperitoneal (i.p.) implantation of a mini-osmotic pump at d12 containing LOX-1 neutralizing antibodies (ePE + LOX-1i, n = 7) or goat IgG as vehicle control (LP + IgG, n = 8 and ePE + IgG, n = 8). Animals were studied at d19. DTAos and PCAs were removed for histologic assessment and isolated vessel experiments, respectively. Fetuses and placentas were weighed individually. Plasma was analyzed for markers of oxidative stress. ePE + IgG DTAo elastin content (an indirect metric of stiffness) was not significantly different from the LP + IgG group. Nonetheless, trending elastin break and sinuosity data (higher number of breaks and lower sinuosity in the ePE + IgG group compared to LP + IgG) suggested increased stiffness in this high cholesterol PE model. LOX-1i appeared to prevent a decrease in elastin. PCAs showed no structural changes with ePE or LOX-1i. ePE PCAs had increased reactivity to the nitric oxide donor sodium nitroprusside and decreased tone that was unaffected by LOX-1i. ePE animals had increased plasma oxLDL and 3-nitrotyrosine that was unaffected by LOX-1i. Taken together, LOX-1i may improve large artery stiffness without mitigation of the oxidative stress or cerebral microvascular dysfunction seen in ePE. Understanding these mechanisms is important in abating the long-term risks of preeclampsia.

Indexed as

Posterior Cerebral ArteryPre-EclampsiaScavenger Receptors, Class EAnimalsAorta, ThoracicDisease Models, AnimalFemaleOxidative StressPregnancyRatsRats, Sprague-DawleyVascular StiffnessOLR1 protein, ratScavenger Receptors, Class EArterial stiffnessLOX-1Microvascular injuryOxidized LDLPreeclampsia

Identifiers

PMID38858329
PMCPMC11438569

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.